Dharmendra Kumar
Swami Vivekanand Subharti University
Formulation and evaluation of nanoparticulate system for cancer therapy
About the Nanocarriers, Drug Delivery & Therapeutics Session
Nanocarrier design and therapeutic delivery are the central themes of this session at the World Nanotechnology Conference. Topics include lipid, polymer and inorganic carriers, extracellular vesicles, biomimetic systems, targeted delivery and controlled or stimuli-responsive release. The scope also covers delivery of genes, RNA, proteins, vaccines and immunotherapeutic agents. Discussions will address formulation, cargo loading, stability, biological interactions and evaluation of delivery performance, with attention to administration routes, manufacturing considerations and the evidence needed to support further therapeutic development.
Abstract Scope and Participation
Abstracts are invited on formulation studies, carrier characterization, release mechanisms, biological assessment and preclinical or clinical delivery research. Contributions comparing platforms or examining limitations in targeting, reproducibility, safety and translation are encouraged. Pharmaceutical scientists, biomedical researchers, chemists, bioengineers, clinicians, industry specialists and students are welcome to exchange approaches spanning early carrier development through application-focused evaluation.
Topics Covered in Nanocarriers, Drug Delivery & Therapeutics
Topic 01
Lipid, Polymer & Inorganic Nanocarriers
Topic 02
Extracellular Vesicles & Biomimetic Carriers
Topic 03
Targeted Drug Delivery
Topic 04
Controlled & Stimuli-Responsive Release
Topic 05
Gene, RNA & Protein Delivery
Topic 06
Nanovaccines & Immunotherapeutic Delivery
Featured Speakers — Nanocarriers, Drug Delivery & Therapeutics 2027
Recent Research Presented at Nanocarriers, Drug Delivery & Therapeutics Sessions
Formulation and evaluation of nanoparticulate system for cancer therapy
One of the primary challenges in pharmaceutical dosage form development is the poor solubility of certain drugs, particularly those classified as Biopharmaceutics Classification System (BCS) Class…
Design and combinatorial synthesis of biomimetic multivariate metal-organic frameworks for efficient drug loading
Multivariate metal–organic frameworks (MOFs) with iso-reticular architectures and spatially programmable functional groups represent an attractive platform for the development of sequence-dependent…
Self-assembly of nobiletin into nanoparticles for improved therapeutic potential
Nobiletin, a biologically active polymethoxyflavone derived from citrus peel has attracted considerable attention due to its demonstrated antioxidant, anti-inflammatory and anticancer properties.…
Improvement of pharmacokinetic parameters of BCS class IV drug for cancer treatment using nanotechnology
Polymeric nanoparticles are widely explored for drug delivery, though challenges remain in drug loading, entrapment, and release. In this study, starch nanoparticles were prepared from unripe banana…
Harnessing silver nanoparticles with pretomanid for enhanced antimycobacterial therapy
The emergence of Multidrug-Resistant Mycobacterium Tuberculosis (MDR-TB) necessitates the development of novel therapeutic strategies to enhance antimycobacterial efficacy. This work explores the…
Nanocarriers
A nanocarrier is nanomaterial being used as a transport molecule for another substance, such as a drug. Common examples include micelles, polymers, carbon-based materials, liposomes and other…
Related Scientific Sessions at World Nano 2027
Why Attend the Nanocarriers, Drug Delivery & Therapeutics Conference 2027
Earn CPD Credit
Participants can earn 1 CPD credit for each hour of attendance.
Present Your Research
Oral and poster slots for original Nanocarriers, Drug Delivery & Therapeutics work, reviewed by the scientific committee.
Network Globally
Meet nanotechnologists, researchers, scientists and engineers from around the world across three days.
Abstract Book Included
In-person and virtual registrations include an electronic copy of the abstract book.
Learn from Keynotes
Plenary lectures from leading voices shaping Nanocarriers, Drug Delivery & Therapeutics research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join World Nano 2027 for the Nanocarriers, Drug Delivery & Therapeutics track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Nanocarriers, Drug Delivery & Therapeutics Conference 2027 — FAQs
What is the Nanocarriers, Drug Delivery & Therapeutics track at World Nano 2027?
The Nanocarriers, Drug Delivery & Therapeutics track is a dedicated stream within World Nano 2027 covering the latest research, innovation, and best practice in Nanocarriers, Drug Delivery & Therapeutics. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Nanocarriers, Drug Delivery & Therapeutics sessions?
Nanotechnology researchers, scientists and engineers, educators and students with an interest in Nanocarriers, Drug Delivery & Therapeutics are all welcome — whether presenting or attending.
Can I present my research in the Nanocarriers, Drug Delivery & Therapeutics track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Is virtual attendance available for Nanocarriers, Drug Delivery & Therapeutics sessions?
Yes. World Nano 2027 is a hybrid conference — attend the Nanocarriers, Drug Delivery & Therapeutics track in person in Singapore or join live online, with on-demand access afterward.
Join the World Nano 2027 delegation
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.